Work for Mersana Therapeutics?

Claim Your Profile

Mersana Therapeutics Logo Image

Mersana Therapeutics

Mersana Therapeutics Banner Image

About Mersana Therapeutics

51-200 Employees
Based in Cambridge, Massachusetts

Mersana is rewriting the rules for immunoconjugate therapies by leveraging their Fleximer platform to create precisely targeted and highly tailored drugs that radically improve patients’ lives. Their Fleximer platform allows them to custom design an ADC with specific properties to overcome limitations of current ADC approaches and increase the drug’s chances of effectively attacking a particular cancer. They engineer immunoconjugates to deliver industry-leading payloads of an array of anti-tumor agents directly to cancerous cells, controlling when, where and how those agents are released. Because they can safely deliver higher quantities of therapeutic payloads directly to a tumor, Mersana’s ADC therapies have the potential to more effectively treat broader populations of cancer patients while significantly reducing the side effects associated with many of today’s cancer treatments.

Ticker:
MRSN
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol